IRCT20110621006852N2已完成2 期
The effect of Atorvastatin in combination to Tenofovir in the treatment of Hepatitis B
Ghoum University of Medical Sciences0 个研究点目标入组 43 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with active hepatitis B that are candidates for anti-viral therapy
- •Viral load greater than 100,000 per ml
- •patients with elevated ALT
排除标准
- •All patients with severe kidney failure.
- •Patients who use suppressor drugs for immune system.
- •Patients with acquired or congenital immune deficiencies.
- •Patients who have had a history of taking statins or any other antiviral medicines in the last six months.
研究者
相似试验
已完成
3 期
Effect of Atorvastatin in Helicobacter pylori eradicatioHelicobacter pylori infection.IRCT20190823044589N1Oroumia University of Medical Sciences120
已完成
3 期
Effect of Atorvastatin on liver function in patients with chronic hepatitis BIRCT2017010631252N3Qom University of Medical Sciences80
已完成
2 期
The effect of atorvastatin on the treatment of secondary pulmonary hypertensiosecondary pulmonary hypertension.Chronic lower respiratory diseasesJ40-J47IRCT201108257411N1Tehran university of medical sciences60
招募中
3 期
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60
招募中
不适用
Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and eveningIRCT20211211053359N1Babol University of Medical Sciences76